Inventor · disambiguated record
John L. Bryant
Also filed as: BRYANT JOHN L
10 granted patents·7 pending applications·433 citations·filing 2004–2020
92Inventor score
Top patents by PatentIndex Score
17 records- 0198US7930104B2Predicting response to chemotherapy using gene expression markersGENOMIC HEALTH INC·Filed 2005·Granted Apr 19, 2011·91 cites·24 claims
- 0296US7723033B2Prediction of likelihood of cancer recurrenceGENOMIC HEALTH INC·Filed 2006·Granted May 25, 2010·28 cites·12 claims
- 0395US7056674B2Prediction of likelihood of cancer recurrenceNSABP FOUNDATION INC·Filed 2004·Granted Jun 6, 2006·148 cites·10 claims
- 0494US7939261B2Expression profile algorithm and test for cancer prognosisGENOMIC HEALTH INC·Filed 2009·Granted May 10, 2011·25 cites·29 claims
- 0594US7622251B2Molecular indicators of breast cancer prognosis and prediction of treatment responseGENOMIC HEALTH INC·Filed 2005·Granted Nov 24, 2009·31 cites·12 claims
- 0693US8591897B2Anti-ERBB2 antibody adjuvant therapyBRYANT JOHN L·Filed 2006·Granted Nov 26, 2013·32 cites·13 claims
- 0792US8597654B2Adjuvant therapy with an anti-ERBB2 antibody conjugated to a maytansiniodBRYANT JOHN L·Filed 2011·Granted Dec 3, 2013·21 cites·15 claims
- 0892US7526387B2Expression profile algorithm and test for cancer prognosisGENOMIC HEALTH INC·Filed 2004·Granted Apr 28, 2009·47 cites·36 claims
- 0988US8868352B2Predicting response to chemotherapy using gene expression markersBAKER JOFFRE B·Filed 2011·Granted Oct 21, 2014·10 cites·21 claims
- 1071US10619215B2Prediction of likelihood of cancer recurrenceGENOMIC HEALTH INC·Filed 2017·Granted Apr 14, 2020·0 cites·11 claims
- 1171US2020299781A1Prediction of Likelihood of Cancer RecurrenceGENOMIC HEALTH INC·Filed 2020·Application pending·0 cites
- 1270US2010184041A1Molecular Indicators of Breast Cancer Prognosis and Prediction of Treatment ResponseBAKER JOFFRE B·Filed 2009·Application pending·0 cites
- 1367US2020155701A1Herceptin® adjuvant therapyGENENTECH INC·Filed 2020·Application pending·0 cites
- 1461US2014086940A1Herceptin® adjuvant therapyGENENTECH INC·Filed 2013·Application pending·0 cites
- 1561US2010267032A1Prediction of Likelihood of Cancer RecurrenceBAKER JOFFRE B·Filed 2010·Application pending·0 cites
- 1659US2015079591A1Predicting response to chemotherapy using gene expression markersGENOMIC HEALTH INC·Filed 2014·Application pending·0 cites
- 1758US2018236093A1Herceptin® adjuvant therapyGENENTECH INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John L. Bryant files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →